GDF ‐15 at admission predicts cardiovascular death, heart failure, and bleeding outcomes in patients with CAD

ConclusionsIn patients with CAD, admission levels of GDF-15 were associated with an increased 1  year risk of CV death, HF, and bleeding outcomes, but not with thrombotic events. GDF-15 may be a prognostic biomarker for CV death, HF, and bleeding outcomes and could be used to refine the risk assessment of these specific clinical outcomes.Trial Registration:ClinicalTrials.gov Identifier: NCT04044066

Source: ESC Heart Failure - August 25, 2023 Category: Cardiology Authors: Jiali Wang, Tao Zhang, Feng Xu, Wei Gao, Ming Chen, Huadong Zhu, Jun Xu, Xinxin Yin, Jiaojiao Pang, Song Zhang, Mengke Wei, Jiahao Chen, Ying Liu, Xuezhong Yu, Derek P. Chew, Yuguo Chen Tags: Original Article Source Type: research